Category: News &amp; Announcements

October 6, 2023

15 December

Whole-gene Humanized Animal Models (WHAM) with CRISPR – Re-imagining how Rare Disease therapeutics are developed

By:

December 15, 2022

23 November

America is finally investing in Biotechnology & Biomanufacturing in a Big Way

By:

November 23, 2022

10 November

[Patent Announcement] InVivo Biosystems has officially been issued a patent on WHAM-humanization in the nematode, C. elegans

By:

November 10, 2022

15 September

If the New Regulation on the Dietary Supplement Industry were to pass, would your Products be Compliant?

By:

September 15, 2022

15 September

What happens if the Dietary Supplement Listing Act of 2022 passes? What if it doesn’t?

By:

September 15, 2022

31 August

[Press Release] InVivo Biosystems and Thaena Announce Novel Metabolite Research Platform With Compelling Longevity and Healthspan Implications and Outcomes

By:

August 31, 2022

25 August

Review: How a Small Worm is Helping Uncover the Pathogenicity of Gene Variants

By:

Ben Jussila ,

August 25, 2022

29 July

A Natural Fit – Using Zebrafish to Evaluate Natural Compounds for Anti-Inflammatory Properties

By:

Laura Taggart-Murphy ,

July 29, 2022

19 April

Differences Between HDR vs NHEJ

By:

Chesley Johnson ,

April 19, 2022

14 April

The Benefits of Standardizing Zebrafish Diets

By:

Emma Lustig ,

Gianna DeMarco ,

Devon Scallion ,

April 14, 2022

6 December

[Press Release] Lifeist Subsidiary Mikra Cellular Sciences to Launch First Product “CELLF” to Combat Brain Fog and Unlock Healthy Aging, Announces U.S. Patent Application and Pre-Clinical Study

By:

December 6, 2021

11 November

Spotlight on InVivo Biosystems’ Zebrafish Work

By:

November 11, 2021

21 June

InVivo Biosystems Launches New Formulation Analysis Platform to Aid Healthy-Aging Product Research and Development

By:

June 21, 2021

24 April

New NIH Grant awarded to InVivo Biosystems to address critical needs in precision medicine research

By:

Kathryn McCormick ,

April 24, 2020

New NIH Grant awarded to InVivo Biosystems to address critical needs in precision medicine research using the model of C. elegans. The grant, titled “Functional

31 March

NemaMetrix Expands Business to Capitalize on In-vivo Solutions to Help Speed Testing for Critical Disease Therapeutics

By:

Hannah Huston ,

March 31, 2020

17 December

CRISPR Benchmark Report Findings

By:

Hannah Huston ,

December 17, 2019

11 October

Bayer and NemaMetrix present C. elegans results at Parasitic Helminths conference in Greece

By:

Janis Weeks, Ph.D. ,

October 11, 2019

How are extreme weather events, such as Hurricane Katrina, spreading heartworms and other parasitic nematodes and what are the implications of their spread?

15 August

C. elegans New Lab Checklist

By:

Sophia Bethel ,

August 15, 2019

Are you starting a new C. elegans lab and feeling overwhelmed with starting from scratch? We want to help make this process as smooth as

29 July

NemaMetrix raises $5 million USD funding and strengthens senior team

By:

July 29, 2019

Investment will be used to further develop the Company’s Precisome platform for functional analysis New investment led by Oregon Venture Fund Dr Stephen Turner

25 February

New Milestone! We can now remove over 43,000 bp from C. elegans genomic DNA!

By:

Yoanne Clovis, Ph.D. ,

February 25, 2019

12k, 24k, 36k…we can now precisely remove over 43k bp from C. elegans genomic DNA! Knocking out genes is a commonly used tool for biologists

25 January

Child Neurology Meeting: Bernard Sachs Award to William B. Dobyns and Precision Medicine in Epilepsy Lecture

By:

January 25, 2019

The Child Neurology Society honored William (Bill) Dobyns for his highly impactful efforts in characterizing child neurology. In a prolific and highly influential carrier, Bill

29 November

PMWC sits down with NemaMetrix to discuss emerging technologies

By:

November 29, 2018

In preparation for the Precision Medicine World Conference on January 20-23rd, 2019, PMWC took a moment to ask us some questions about the new and

16 November

NemaMetrix wins “Job Creation” Award at Inaugural Innovation and Talent Celebration

By:

November 16, 2018

Thursday November 15th, 2018 – NemaMetrix wins the “Job Creation” Award at the RG Media Company’s inaugural Innovation and Talent Celebration. The event was organized

1 November

KCNQ2 Cures Summit – Patient Family Passion and Involvement

By:

November 1, 2018

The passion to find answers is inspiring. I had the good fortune to attend the KCNQ2 Cure Summit 2018. Meeting the patient families and seeing

29 March

My last grant application to the NIH proposing experiments in C. elegans got a perfect score!

By:

March 29, 2018

‘Those of us who have studied invertebrate model organisms throughout our careers have been nervous that NIH study sections will shut the door on our

12 December

NemaMetrix becomes the first “Most Innovative” health startup at Demo Day!

By:

December 12, 2017

NemaMetrix Inc. is the winner of the first “Most Innovative” health startup at Demo Day organized by CBInsights.

12 December

DD News features NemaMetrix in its latest issue on Animal Models of Disease

By:

December 12, 2017

The latest issue of Drug Discovery News (DDNews) features a special report on Animal Models of Disease, highlighting the NemaMetrix/Knudra merger and the value of

28 November

Scientists study how cancer spreads by recording a time-lapse of C. elegans

By:

Matt Beaudet, CEO ,

November 28, 2017

Scientists from Duke University captured the cellular break-ins in C. elegans, a transparent worm that’s often used as a model for human biology. The cellular

14 November

NemaMetrix and Knudra Transgenics announce merger

By:

November 14, 2017

NemaMetrix and Knudra Transgenics announce merger to provide fast genotype-to-phenotype answers. The combined company will operate under NemaMetrix Inc.

26 April

NemaMetrix Inc., An American Innovation Success Story

By:

April 26, 2017

NemaMetrix Inc. was selected as the only company representing the state of Oregon by the Science Coalition in its latest Sparking Economic Growth reports released

26 October

Nemametrix and Knudra Transgenics Join Forces to Expand Sales and Marketing Initiatives

By:

October 26, 2016

Nemametrix Inc., a life sciences startup that created the innovative ScreenChip System for drug screening, mutant phenotyping, and toxicological assessment, has entered into a marketing

20 September

ScreenChip Platform Recognized by the White House

By:

September 20, 2014

The NemaMetrix ScreenChip platform technology was recognized by the White House as one of the breakthrough life science research technologies. CEO Matt Beaudet spoke with

13 April

NemaMetrix announces GAP funding

By:

April 13, 2014

NemaMetrix announces being awarded $249,000 in GAP funding from Oregon Nanoscience and Microtechnologies Institute (ONAMI) to fund “proof-of-concept” work and to fuel development towards

28 January

NemaMetrix Announces NIH funding

By: